AQR CAPITAL MANAGEMENT LLC
Position in ARWR — Arrowhead Pharmaceuticals, Inc.
CIK 1167557
Greenwich, CT
Position in ARWR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$16,207,609
+$5,723,543 QoQ
Shares Held
198,842
+18.9% QoQ
Ownership
0.141%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#74
of 497 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AQR CAPITAL MANAGEMENT LLC holds $5,647,082,401 across 216 Biotechnology names. ARWR ranks #32 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,126,080 | $702,155,918 | |
| 2 | INCY |
Incyte Corp
|
5,320,901 | $603,177,333 | |
| 3 | EXEL |
Exelixis, Inc.
|
11,023,943 | $599,812,735 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
1,522,568 | $366,893,205 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
5,699,541 | $326,127,732 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
616,170 | $306,070,117 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
1,295,450 | $242,611,869 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,305,412 | $241,404,446 |
All Filings in ARWR
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,207,609 | 198,842 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $10,484,066 | 167,210 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $9,782,764 | 147,353 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $4,926,033 | 142,825 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $2,407,144 | 152,351 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $516,044 | 40,506 | Shares | Defined | 2025-05-15 | |
| 2022-12-31 | $244,333 | 6,024 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $758,563 | 22,952 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $688,003 | 19,540 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $5,362,342 | 116,598 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $3,204,279 | 48,330 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $3,595,530 | 57,593 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $3,740,648 | 45,166 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $1,721,009 | 25,954 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $2,769,799 | 36,098 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $3,075,603 | 71,426 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $12,366,592 | 286,330 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $12,601,979 | 438,025 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||